Search hospitals > Texas > Conroe
Houston Methodist The Woodlands Hospital
Claim this profileConroe, Texas 77385
Global Leader in Parotid Gland Cancer
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Serous Cystadenocarcinoma
Conducts research for Cervical Adenocarcinoma
19 reported clinical trials
14 medical researchers
Summary
Houston Methodist The Woodlands Hospital is a medical facility located in Conroe, Texas. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Serous Cystadenocarcinoma, Cervical Adenocarcinoma and other specialties. Houston Methodist The Woodlands Hospital is involved with conducting 19 clinical trials across 68 conditions. There are 14 research doctors associated with this hospital, such as Jun Zhang, Aparna Kamat, MD, Siddhartha Ganguly, and Eric Bernicker, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Breast Cancer
ER positive
HER2 positive
ER negative
Top PIs
Jun ZhangHouston Methodist Hospital5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
28 reported clinical trials
43 drugs studied
Aparna Kamat, MDHouston Methodist Sugar Land Hospital8 years of reported clinical research
Studies Ovarian Cancer
Studies Serous Cystadenocarcinoma
7 reported clinical trials
18 drugs studied
Siddhartha GangulyHouston Methodist Hospital7 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
6 reported clinical trials
10 drugs studied
Eric Bernicker, MDHouston Methodist Hospital10 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
9 drugs studied
Clinical Trials running at Houston Methodist The Woodlands Hospital
Breast Cancer
Lung Cancer
Ovarian Cancer
Parotid Gland Cancer
Breast cancer
Multiple Myeloma
Uterine Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Houston Methodist The Woodlands Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.